🇺🇸

US SEC Filing Intelligence

· daily

S&P 500 Industrials Sector SEC Filings — August 26, 2026

This digest covers four filings from the S&P 500 Industrials sector, with a strong concentration in waste management (Republic Services and Waste Management) and a notable insider sale at Deere & Co. The most critical development is the CEO succession at Waste Management, signaling a smooth leadership transition but also potential strategic shifts under incoming CEO John Morris. Insider activity is mixed: a massive $48.4M purchase by Republic Services' 10% owner Cascade Investment signals strong conviction, while Deere's President sold $1.73M under a 10b5-1 plan, which is less alarming but still a notable insider sale. Period-over-period data was limited in these filings, but the capital allocation and insider patterns point to a sector where management is confident in waste services (Republic) while agricultural machinery (Deere) faces headwinds. The overarching theme is a tale of two subsectors: waste management shows insider buying and stable leadership, while Deere's insider sale and lack of positive catalysts warrant caution. No filings were excluded as all fall within the S&P 500 Industrials scope.

4 high priority 4 total filings
· daily

US Material Events SEC 8-K Filings — August 26, 2026

The August 26, 2026, filing batch reveals a market dominated by significant M&A activity and capital structure events, with 50 filings analyzed. Key themes include a major biotech licensing deal (Biohaven), a large-scale SPAC merger (Bleichroeder/Pasqal), and a transformative acquisition in the industrial sector (Somnigroup/Leggett & Platt). Period-over-period data is sparse in these 8-K filings, but forward-looking statements from Gevo (reaffirming $60M+ Adjusted EBITDA) and CuriosityStream (raised guidance) signal strong operational momentum. Insider activity is limited, but capital allocation actions like Saratoga Investment's $85M debt issuance and Cheetah Net's $35M ATM program indicate varied financing strategies. The most critical developments are the high-redeemer SPAC merger and the completion of a $2.3B all-stock acquisition, which carry significant implications for the combined entities' valuations and market positioning.

50 high priority 50 total filings
· daily

Insider Trading Pulse — August 26, 2026

The August 26, 2026 insider trading digest reveals a pronounced bearish sentiment among corporate insiders, with 13 sell transactions totaling over $13.5 million, heavily concentrated in high-growth tech names like DoorDash and Intapp, where CEO Tony Xu sold $6.8M and CEO John Hall sold $1.94M, both under Rule 10b5-1 plans. A notable insider buying cluster emerged in distressed/special situations, with Jushi Holdings CEO James Cacioppo investing $184K at $0.48 and Nu Ride director Alexandre Zyngier accumulating shares at $1.73, signaling contrarian conviction. The most significant capital flow was MetLife Investment Management's $11.3M rotation into preferred shares of Calamos funds, while simultaneously exiting $22M from other Calamos preferreds, indicating a strategic portfolio rebalancing. Period-over-period trends show no direct revenue comparisons, but the pattern of CEO selling at elevated prices (DoorDash at $230, Dell at $438) versus insider buying in beaten-down names (Jushi at $0.48, Genasys at $1.55) suggests a market at a potential inflection point between overvalued growth and undervalued value. The overall tone is mixed, with aggressive selling in high-flying tech contrasting with opportunistic buying in turnaround stories.

50 high priority 50 total filings
· daily

Dow Jones 30 Stocks SEC Filings — August 26, 2026

The four filings for August 26, 2026, paint a picture of a market bifurcated by the AI boom. NVIDIA continues to dominate, reporting staggering revenue growth of 106% YoY and 18% QoQ to $96.2B, driven by its Data Center segment, but a sequential slowdown in net income growth and the exclusion of China from its Q3 outlook introduce caution. In contrast, Salesforce shows a more tempered growth story with 10% YoY revenue growth, but faces margin compression (-250 bps YoY) as it invests heavily in AI, signaling that the AI transition is costly for non-semiconductor players. The American Express trust filing, while lower materiality, reveals a stable but shrinking credit portfolio, with improving credit quality metrics (net charge-offs down to 1.23% from 1.33%) offset by a declining account base (down to 12.3M from 13.3M). The overarching theme is that AI is the dominant growth driver, but its benefits are unevenly distributed, creating both massive opportunities and significant margin pressure across the Dow 30 landscape. Key period-over-period trends show a clear divergence: NVIDIA's hyper-growth versus Salesforce's profitable but margin-compressed expansion, while AmEx's trust data suggests a cautious consumer credit environment. The most critical development is NVIDIA's Q3 guidance excluding China revenue, which introduces a new geopolitical risk vector for the company's future growth trajectory. Portfolio-level patterns highlight a 'two-speed' AI economy where infrastructure providers capture exponential value while software and consumer-facing companies bear the cost of implementation. All four filings are within the scope of the USA Dow Jones 30 stream, as NVIDIA, Salesforce, and American Express are index constituents, and the AmEx trust filing is a related entity. No filings were excluded.

1 high priority 3 medium 4 total filings
· daily

Global High-Priority Regulatory Events — August 26, 2026

The 47 filings from August 26, 2026, reveal a market sharply bifurcated between distressed entities undergoing insolvency or facing delisting, and a flurry of M&A and capital restructuring activity. A dominant theme is the wave of corporate distress in India, with Simbhaoli Sugars, Future Consumer, and SKIL Infrastructure all deep in insolvency proceedings, while American Resources Corp and Atlantic American Corp face Nasdaq delisting for delinquent filings. On the M&A front, major transactions include the $2.3B all-stock acquisition of Leggett & Platt by Somnigroup, the completion of AstroNova's take-private by Arcline, and a significant SPAC merger for Bleichroeder Acquisition Corp. II with Pasqal, though the latter saw heavy redemptions. A notable pattern is the surge in issuer tender offers from private credit and BDC funds (Blue Owl, Crescent, Brookfield), offering liquidity but often with low participation, signaling a cautious investor base. Insider activity was sparse, but the lack of insider tendering in several BDC offers suggests management confidence. The period-over-period data is most impactful in the distressed filings, where Simbhaoli Sugars' revenue collapsed 37% YoY and losses widened 13%, underscoring the severity of the insolvency. The overall picture is one of aggressive capital reallocation, with distressed assets being shed and capital flowing into strategic consolidations and private market liquidity events.

47 high priority 47 total filings
· daily

US SEC Filings Daily Market Digest — August 26, 2026

Today's filings reveal a market bifurcated between aggressive capital deployment (M&A, SPACs, buybacks) and operational headwinds (cyberattacks, supply chain constraints, revenue declines). The most significant development is the Ursa Major de-SPAC merger, a $2.3B bet on defense tech with explosive revenue growth but pre-profit status, signaling strong investor appetite for high-growth, capital-intensive sectors. Conversely, the Boston Scientific cyberattack and TORM's 25% profit decline highlight operational fragility in healthcare and cyclical weakness in shipping. A clear sector theme is the 'de-SPAC' wave, with three major transactions (Ursa Major, Gravitics, Evernorth) moving toward closure, each with distinct risk/reward profiles. Insider activity is mixed but notable, with a Webull president selling $476K and a Biohaven CLO selling $458K, contrasting with a CEO exercising options at Applied Energetics. Capital allocation trends show a preference for debt reduction (Generation Income Properties) and share repurchases (News Corp, Avalanche Treasury) over dividend growth. Overall, the digest points to a market favoring defense, space, and crypto infrastructure, while punishing companies with execution risks or cyclical exposure.

19 high priority 31 medium 50 total filings
· daily

S&P 500 Consumer Discretionary Sector SEC Filings — August 26, 2026

All four filings originate from DoorDash, Inc., a single S&P 500 Consumer Discretionary constituent, and reveal a coordinated wave of insider selling across the C-suite and board. The CEO, CAO, General Counsel, and a Director all executed sales under Rule 10b5-1 plans, totaling approximately $9.8 million in proceeds, with the CEO alone selling $6.8 million worth of stock. While 10b5-1 plans indicate pre-scheduled trades, the concentration and timing of these sales—particularly the CEO's conversion of low-cost options ($7.16 strike) followed by immediate sales at ~$230—suggest a deliberate monetization of equity awards. No forward-looking guidance, capital allocation changes, or period-over-period financial comparisons were provided in these filings, limiting the ability to assess fundamental trends. The lack of bullish signals (no buybacks, dividends, or insider purchases) combined with the breadth of selling creates a cautious near-term outlook for the stock. Investors should monitor upcoming earnings calls for commentary on growth sustainability and margin trends to contextualize this insider activity.

4 high priority 4 total filings
· daily

S&P 500 Healthcare Sector SEC Filings — August 26, 2026

The S&P 500 Healthcare sector is flashing a starkly divergent signal on August 26, 2026. While the broader sector shows no material period-over-period revenue or margin trends from these filings, a critical operational risk has emerged at **Boston Scientific Corp**, which disclosed a major cybersecurity incident causing global operational disruptions, including halted order processing and shipping. This event, with a materiality score of 8/10, represents the most significant single-company risk in the digest. Concurrently, insider trading activity paints a bearish picture for the medical device sub-sector, with executives at **Stryker Corp**, **Edwards Lifesciences**, and **Thermo Fisher Scientific** all executing sales, including a substantial $2.79M sale by an Edwards executive. The only countervailing positive signal is a director's purchase at **Boston Scientific Corp** following the cyber incident, suggesting a potential value opportunity. The overall portfolio-level pattern is one of elevated operational risk and a lack of management conviction in the medical device space, contrasted with a quiet but potentially opportunistic insider buy in the face of adversity.

6 high priority 1 medium 7 total filings
· daily

US Earnings Financial Results SEC Filings — August 26, 2026

This batch of 16 filings reveals a bifurcated market: dominant AI players like NVIDIA and Synopsys are delivering explosive growth (NVIDIA revenue +106% YoY, Synopsys +42%), while consumer-facing and industrial names show mixed results with revenue declines or modest growth. A clear turnaround theme is emerging in several companies (J M Smucker, Bath & Body Works, Movado Group) where profits are recovering sharply even on flat or declining sales, driven by cost controls and margin expansion. However, this is offset by significant cash burn and working capital pressure across the board—inventories are rising at Bath & Body Works (+26%), Movado (+24%), and NVIDIA (+$10.2B), while cash positions are declining at Box, CFN Enterprises, and Zoom. Insider activity is notably absent across most filings, but capital allocation is aggressive: Zoom bought back $353M in a quarter, Box repurchased $185.7M in six months, and NVIDIA issued $24.9B in new debt. The SPAC sector remains a dead zone, with BOA Acquisition Corp. II and Alpha Star Acquisition Corp both burning cash with no business combination in sight. The overarching theme is that operational discipline is driving profit recovery, but balance sheet health and cash generation remain critical watchpoints.

16 high priority 16 total filings
· daily

US Executive Compensation Proxy SEC Filings — August 26, 2026

This digest covers four pre-analyzed proxy filings, all centered on corporate control events (mergers, annual meetings) with significant governance implications. The dominant theme is M&A activity, with two high-materiality filings (Caesars Entertainment and Iridium Communications) involving stockholder votes on transformative mergers, both carrying the risk that abstentions effectively count as 'against' votes. The remaining two filings (TurnOnGreen and Citius Oncology) are routine annual meeting proxies but include notable governance proposals, such as a reverse stock split and a new stock incentive plan at TurnOnGreen. No period-over-period financial comparisons or insider trading data were available in these filings, limiting trend analysis. The key actionable insight is the binary risk in the merger votes, where low retail turnout could derail deals. The Iridium/Rocket Lab merger is particularly material (9/10), with a complex two-step structure and a 40% value threshold for the second step, creating a unique catalyst for arbitrageurs.

4 high priority 4 total filings
· daily

US IPO Pipeline SEC S-1 Filings — August 26, 2026

The sole filing in today's IPO Pipeline stream is Daré Bioscience's S-1 registration for a proposed public offering, marking a critical juncture for the company as it transitions to a dual-path business model (503B compounded products and consumer health). The filing follows a private placement and registered direct offering that closed on August 17, 2026, at $1.37 per share, indicating strong capital-raising momentum. However, the company faces existential risks: a Nasdaq delisting hearing was held on August 25, 2026, and it has negative stockholders' equity with no material revenue expected from product sales in 2026. The sentiment is mixed, reflecting the high-risk/high-reward nature of the offering. The S-1 provides a detailed look at the company's operational pivot, with its first 503B product (DARE to PLAY Sildenafil Cream) available for pre-order since December 2025 and its first consumer health product (Flora Sync LF5) launched in June 2026. Investors should weigh the potential upside of the new product lines against the immediate need for additional capital and the overhang of the Nasdaq compliance issue.

1 high priority 1 total filings
· daily

US SEC Trading Suspension Halt Orders — August 26, 2026

The August 26, 2026 trading suspension and delisting landscape is dominated by a cluster of Nasdaq compliance failures, with three micro-cap companies (American Resources Corp, Atlantic American Corp, and CaliberCos Inc.) receiving deficiency or delisting notices within a single week. This pattern suggests a potential tightening of Nasdaq's enforcement or a broader financial reporting strain among smaller issuers. In contrast, Avalanche Treasury Corp successfully resolved its deficiency, providing a positive data point. The voluntary delisting of Kraft Heinz Co from Nasdaq to transfer to the NYSE is a non-event from a regulatory risk perspective but highlights a strategic listing choice. Period-over-period data from the filings is sparse, but the aggregate trend shows a 60% failure rate (3 out of 5) for companies facing compliance issues, with two of those failures stemming from chronic late filings, indicating deeper operational and financial control problems. The most critical development is the high materiality (8-9/10) of the three negative delisting notices, which carry immediate downside risk for equity holders. No insider trading activity or forward-looking guidance was reported in any of the filings, limiting the depth of sentiment analysis but also signaling a lack of management-led confidence signals during these critical periods.

5 high priority 5 total filings
· daily

US Executive Officer Management Changes SEC — August 26, 2026

This digest of 20 regulatory filings reveals a period of significant leadership transition across the US equity markets, with a notable concentration of CEO and C-suite changes in the industrial and technology sectors. The most material development is the planned retirement of Waste Management's CEO Jim Fish after a decade, a well-flagged succession that signals stability. In contrast, the CFO departures at Duos Technologies and SS Innovations, while amicable, create near-term uncertainty. A clear theme of strategic realignment is evident, with Micron Technology promoting internally to align with its AI-driven growth strategy and Gevo expanding executive roles to support commercial execution. The data also highlights a strong focus on long-term incentive alignment, with Key Tronic and Novelis implementing performance-based compensation tied to EBITDA and project milestones. While most filings are routine, the combination of a major CEO transition, multiple CFO changes, and strategic promotions creates a landscape of both risk and opportunity for investors monitoring management quality and strategic direction.

20 high priority 20 total filings
· daily

US Corporate Board Director Changes SEC Filings — August 26, 2026

The August 26, 2026, digest reveals a period of significant executive and board-level transitions across the US market, with a clear emphasis on succession planning and strategic realignment. The most critical development is the CEO transition at Waste Management (WM), a Dow Jones component, signaling a major leadership change for a market leader. The filings also show a strong trend of companies appointing new CFOs (CuriosityStream, Duos Technologies, CPI Card Group) and promoting internal talent to key operational roles (Micron, Gevo, McEwen), suggesting a focus on execution and growth. While most changes are routine, the shareholder dissent at Helen of Troy's AGM (14.1% against for one director) and the departure of a director to join Reddit (Rumble) provide nuanced insights into governance and talent dynamics. Overall, the period is characterized by proactive board and management refreshment, with a positive tilt in sentiment, particularly for companies with clear growth strategies like Micron and Gevo. The data reveals no significant insider selling or negative period-over-period trends, but rather a focus on positioning for future performance, with several companies reaffirming or raising guidance (Gevo, CuriosityStream).

20 high priority 20 total filings
· daily

USA Insider Trading Pulse — August 26, 2026

The August 26, 2026 insider trading pulse reveals a pronounced divergence between executive selling and strategic buying. A dominant theme is the heavy, pre-planned selling by C-suite executives at high-growth tech companies like DoorDash, Intapp, and Dell Technologies, where CEO Tony Xu alone monetized $6.8M in stock. Conversely, a clear contrarian buying signal emerges from beaten-down sectors, with the CEO of Jushi Holdings making a $184K open-market purchase and the CEO of Eos Energy receiving substantial equity awards, signaling long-term conviction. A significant institutional capital rotation is underway within the Calamos fund complex, where MetLife Investment Management is executing a multi-million dollar arbitrage, selling preferred shares in one fund to buy in another. The data also shows a cluster of director-level stock awards at Aqua Metals, suggesting a board-level refresh or incentive program. Overall, the pulse points to a market where insiders are taking profits in overvalued growth names while deploying capital into distressed value and special situations.

50 high priority 50 total filings
· daily

US Merger & Acquisition SEC Filings — August 26, 2026

This USA M&A & Takeover Activity digest covers 13 pre-analyzed SEC filings, dominated by SPAC-related amendments, extensions, and business combination approvals alongside two completed M&A transactions of significant scale. The most critical development is the execution of two major acquisitions: Somnigroup's $2.3 billion all-stock acquisition of Leggett & Platt, which is expected to generate $75 million in run-rate synergies but also faces $60 million in annualized non-cash charges, and Vireo Growth's acquisition of C21 Investments, expanding its Nevada footprint to 14 dispensaries and 159,000 sq. ft. of cultivation capacity. On the SPAC front, Bleichroeder Acquisition Corp. II secured shareholder approval for its combination with Pasqal but faced a high 26 million share redemption rate, signaling mixed investor sentiment. The period-over-period enriched data reveals an active market for deSPAC processes, with several SPACs extending their deadlines (Inflection Point, Cayson, Black Hawk via a convertible note), indicating persistent challenges in finalizing deals. Insider activity is limited, but capital allocation data shows a strategic shift towards vertical integration and synergy realization, as seen in the Somnigroup and Vireo transactions. A notable portfolio-level pattern is the heightened level of gating events (shareholder meetings, redemption decisions) over the coming weeks, presenting clear catalysts for volatility in the target equities.

13 high priority 13 total filings
· monthly

US Pre-Market SEC Filings Roundup — August 26, 2026

Overnight filings from August 25-26, 2026, reveal a market bifurcated between defense/space SPACs and industrial/energy companies facing cyclical headwinds. The most significant development is the Bleichroeder Acquisition Corp. III / Ursa Major de-SPAC, a $2.3B post-money valuation deal with a $350M PIPE, signaling strong institutional appetite for defense tech. Conversely, TORM plc's 25% YoY net profit decline and Donaldson's mixed results (record sales but Industrial Filtration down 2%) highlight margin pressure in cyclical sectors. Insider activity is a key theme: significant sells by CORPAY ($1.59M) and Allison Transmission ($2.94M) contrast with a massive insider purchase of Expion360 convertible debentures ($20.3B notional), suggesting a high-conviction bet on a turnaround. The Equinox Gold 13G filing from Fairfax indicates a passive, value-oriented stake in gold. Cybersecurity risk is elevated with Boston Scientific's operational disruption, while the Charter/Cox Communications deal closes, creating a cable giant. The period-over-period data shows a clear divergence: growth in defense/space (Ursa Major revenue +143% YoY) vs. contraction in shipping (TORM revenue -11.8%) and select industrials.

29 high priority 21 medium 50 total filings
· daily

S&P 500 Technology Sector SEC Filings — August 25, 2026

The five filings from the S&P 500 Technology sector reveal a concentrated pattern of insider selling, with four companies reporting significant transactions by top executives and directors, all executed under Rule 10b5-1 plans. This broad-based selling, particularly the $5.08M sale by Micron Technology's CEO and the $913K sale by CrowdStrike's CEO, suggests a cautious or profit-taking stance among management, despite the lack of negative guidance changes. Intuit's filing stands out as the only one with a positive capital allocation signal, announcing a $1.38 per share dividend, though it lacks specific period-over-period financial performance data. The absence of revenue or earnings figures in Intuit's 8-K and the lack of any forward-looking guidance changes across the filings limit the ability to identify sector-wide growth or margin trends. Overall, the dominant theme is a high level of insider monetization, which warrants close monitoring for potential sector headwinds or valuation concerns, while Intuit's dividend increase provides a contrasting signal of shareholder return commitment.

4 high priority 1 medium 5 total filings
· daily

US Activist Hedge Fund Institutional SEC 13D 13G — August 25, 2026

This digest of 42 filings reveals a landscape dominated by significant activist and institutional activity, with a clear focus on corporate governance and value realization. The most critical development is the transformative $9.5B+ transaction between **Cox Enterprises and Charter Communications**, which reshapes the telecom landscape and creates a powerful new shareholder with board control. Activist campaigns are intensifying, with **Goldenwise Capital** nominating a director at **Phunware** and **Fund 1 Investments** taking a 9.9% activist stake in **Xponential Fitness**, signaling a push for operational improvements. A notable pattern of insider selling is emerging, with **Diana Shipping** reducing its stake in **Genco Shipping** by 1.2M shares and **Engine Capital** exiting its position in **Civeo Corp** below the 5% threshold, suggesting sector-specific concerns in shipping and energy services. Conversely, **Paine Schwartz** is aggressively accumulating shares of **Suja Life**, increasing its majority stake to 65.5% through five consecutive days of purchases at rising prices, a strong vote of confidence. The data also highlights significant dilution risk at **Edesa Biotech**, where a group's potential ownership could reach 27.8% if ownership limitations are removed. Overall, the period shows a market where large blockholders are actively deploying capital to influence strategy, while others are taking profits or reducing exposure, creating a dynamic environment for event-driven investors.

22 high priority 20 medium 42 total filings
· daily

S&P 500 Financials Sector SEC Filings — August 25, 2026

The August 25, 2026 filing batch for the S&P 500 Financials stream is dominated by insider selling activity and low-materiality administrative changes. Six of the seven filings are newly published, centered on a routine but broad board-level resignation across three Morgan Stanley crypto trust entities (Bitcoin, Solana, Ethereum), which carries negligible financial impact. The remaining three filings are Form 4 insider sales totaling approximately $3.9 million, executed by senior executives, directors, and a major 10% owner at Northern Trust, Chubb, and AFLAC. Notably, all three insider sellers are reducing positions, with two transactions executed under pre-arranged 10b5-1 plans, signaling potential portfolio rebalancing or tax planning rather than operational distress. The data reveals no period-over-period comparisons, forward-looking guidance, capital allocation changes, or M&A activity, limiting the breadth of signals but highlighting a uniform negative sentiment bias from insider transactions. The key takeaway is a cautionary signal from top-tier insiders at blue-chip financials, particularly Chubb's director selling nearly 30% of his disclosed position, which warrants monitoring for broader sector confidence. The seven filings provide actionable intelligence primarily in the insider activity and event-driven risk categories, with no immediate growth or guidance catalysts.

7 high priority 7 total filings